219 related articles for article (PubMed ID: 14662770)
1. Epidermal growth factor increases coactivation of the androgen receptor in recurrent prostate cancer.
Gregory CW; Fei X; Ponguta LA; He B; Bill HM; French FS; Wilson EM
J Biol Chem; 2004 Feb; 279(8):7119-30. PubMed ID: 14662770
[TBL] [Abstract][Full Text] [Related]
2. Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription.
Song LN; Herrell R; Byers S; Shah S; Wilson EM; Gelmann EP
Mol Cell Biol; 2003 Mar; 23(5):1674-87. PubMed ID: 12588987
[TBL] [Abstract][Full Text] [Related]
3. Site-specific androgen receptor serine phosphorylation linked to epidermal growth factor-dependent growth of castration-recurrent prostate cancer.
Ponguta LA; Gregory CW; French FS; Wilson EM
J Biol Chem; 2008 Jul; 283(30):20989-1001. PubMed ID: 18511414
[TBL] [Abstract][Full Text] [Related]
4. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
Wang Q; Lu J; Yong EL
J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
[TBL] [Abstract][Full Text] [Related]
5. Interaction of beta-catenin and TIF2/GRIP1 in transcriptional activation by the androgen receptor.
Song LN; Gelmann EP
J Biol Chem; 2005 Nov; 280(45):37853-67. PubMed ID: 16141201
[TBL] [Abstract][Full Text] [Related]
6. Heregulin-induced activation of HER2 and HER3 increases androgen receptor transactivation and CWR-R1 human recurrent prostate cancer cell growth.
Gregory CW; Whang YE; McCall W; Fei X; Liu Y; Ponguta LA; French FS; Wilson EM; Earp HS
Clin Cancer Res; 2005 Mar; 11(5):1704-12. PubMed ID: 15755991
[TBL] [Abstract][Full Text] [Related]
7. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
[TBL] [Abstract][Full Text] [Related]
8. Potential action of IGF-1 and EGF on androgen receptor nuclear transfer and transactivation in normal and cancer human prostate cell lines.
Orio F; Térouanne B; Georget V; Lumbroso S; Avances C; Siatka C; Sultan C
Mol Cell Endocrinol; 2002 Dec; 198(1-2):105-14. PubMed ID: 12573820
[TBL] [Abstract][Full Text] [Related]
9. Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways.
Ueda T; Bruchovsky N; Sadar MD
J Biol Chem; 2002 Mar; 277(9):7076-85. PubMed ID: 11751884
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic relationship between androgen receptor polyglutamine tract truncation and androgen-dependent transcriptional hyperactivity in prostate cancer cells.
Wang Q; Udayakumar TS; Vasaitis TS; Brodie AM; Fondell JD
J Biol Chem; 2004 Apr; 279(17):17319-28. PubMed ID: 14966121
[TBL] [Abstract][Full Text] [Related]
11. Proteasome activity is required for androgen receptor transcriptional activity via regulation of androgen receptor nuclear translocation and interaction with coregulators in prostate cancer cells.
Lin HK; Altuwaijri S; Lin WJ; Kan PY; Collins LL; Chang C
J Biol Chem; 2002 Sep; 277(39):36570-6. PubMed ID: 12119296
[TBL] [Abstract][Full Text] [Related]
12. Androgens modulate expression of transcription intermediary factor 2, an androgen receptor coactivator whose expression level correlates with early biochemical recurrence in prostate cancer.
Agoulnik IU; Vaid A; Nakka M; Alvarado M; Bingman WE; Erdem H; Frolov A; Smith CL; Ayala GE; Ittmann MM; Weigel NL
Cancer Res; 2006 Nov; 66(21):10594-602. PubMed ID: 17079484
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancer.
Tan JA; Bai S; Grossman G; Titus MA; Harris Ford O; Pop EA; Smith GJ; Mohler JL; Wilson EM; French FS
Mol Cell Endocrinol; 2014 Jan; 382(1):302-313. PubMed ID: 24103312
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor induces bladder cancer cell proliferation through activation of the androgen receptor.
Izumi K; Zheng Y; Li Y; Zaengle J; Miyamoto H
Int J Oncol; 2012 Nov; 41(5):1587-92. PubMed ID: 22922989
[TBL] [Abstract][Full Text] [Related]
15. Reconfiguring the AR-TIF2 Protein-Protein Interaction HCS Assay in Prostate Cancer Cells and Characterizing the Hits from a LOPAC Screen.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2016 Oct; 14(8):453-477. PubMed ID: 27606620
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of androgen receptor transcriptional activity by the nuclear receptor co-repressor (N-CoR).
Berrevoets CA; Umar A; Trapman J; Brinkmann AO
Biochem J; 2004 May; 379(Pt 3):731-8. PubMed ID: 14744261
[TBL] [Abstract][Full Text] [Related]
17. Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation-Drug leads for metastatic castration resistant prostate cancer.
Fancher AT; Hua Y; Close DA; Xu W; McDermott LA; Strock CJ; Santiago U; Camacho CJ; Johnston PA
SLAS Discov; 2023 Oct; 28(7):325-343. PubMed ID: 37549772
[TBL] [Abstract][Full Text] [Related]
18. Suppression of androgen receptor-mediated transactivation and cell growth by the glycogen synthase kinase 3 beta in prostate cells.
Wang L; Lin HK; Hu YC; Xie S; Yang L; Chang C
J Biol Chem; 2004 Jul; 279(31):32444-52. PubMed ID: 15178691
[TBL] [Abstract][Full Text] [Related]
19. High-Content Screening Campaign to Identify Compounds That Inhibit or Disrupt Androgen Receptor-Transcriptional Intermediary Factor 2 Protein-Protein Interactions for the Treatment of Prostate Cancer.
Fancher AT; Hua Y; Camarco DP; Close DA; Strock CJ; Johnston PA
Assay Drug Dev Technol; 2018; 16(6):297-319. PubMed ID: 30109944
[TBL] [Abstract][Full Text] [Related]
20. Modulation of androgen receptor transactivation by FoxH1. A newly identified androgen receptor corepressor.
Chen G; Nomura M; Morinaga H; Matsubara E; Okabe T; Goto K; Yanase T; Zheng H; Lu J; Nawata H
J Biol Chem; 2005 Oct; 280(43):36355-63. PubMed ID: 16120611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
